PSCBF
Price:
$0.11
Market Cap:
$210.57K
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and var...[Read more]
Industry
Biotechnology
IPO Date
2015-02-03
Stock Exchange
OTC
Ticker
PSCBF
According to Pascal Biosciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -11.00. This represents a change of 198.74% compared to the average of -3.68 of the last 4 quarters.
The mean historical PE Ratio of Pascal Biosciences Inc. over the last ten years is -2.49. The current -11.00 PE Ratio has changed 44.17% with respect to the historical average. Over the past ten years (40 quarters), PSCBF's PE Ratio was at its highest in in the August 2023 quarter at 89.11. The PE Ratio was at its lowest in in the May 2025 quarter at -66.41.
Average
-2.49
Median
-0.00
Minimum
-11.84
Maximum
-0.00
Discovering the peaks and valleys of Pascal Biosciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.50%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -47.89%
Minimum Annual PE Ratio = -11.84
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -6.17 | -47.89% |
| 2024 | -11.84 | 196.12% |
| 2023 | -4.00 | 41.29% |
| 2022 | -2.83 | 33.14% |
| 2021 | -0.01 | 8.11% |
| 2020 | -0.00 | 1.53% |
| 2019 | -0.00 | 67.65% |
| 2018 | -0.00 | -33.73% |
| 2017 | -0.00 | 101.79% |
| 2016 | -0.00 | 4.50% |
The current PE Ratio of Pascal Biosciences Inc. (PSCBF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.34
5-year avg
-4.97
10-year avg
-2.49
Pascal Biosciences Inc.’s PE Ratio is greater than BerGenBio ASA (-15.91), less than Intellipharmaceutics International Inc. (-1.72), less than Dogecoin Cash, Inc. (-2.07), less than Oxford Cannabinoid Technologies Holdings Plc (-0.19), less than Field Trip Health & Wellness Ltd. (-0.34), less than Guardion Health Sciences, Inc. (26.14), less than Tryp Therapeutics Inc. (-1.10), less than Invictus MD Strategies Corp. (-0.00), less than Epsilon Healthcare Limited (-6.83), less than Pixium Vision S.A. (-1.92),
| Company | PE Ratio | Market cap |
|---|---|---|
| -15.91 | $9.49B | |
| -1.72 | $4.96M | |
| -2.07 | $1.38M | |
| -0.19 | $3.05M | |
| -0.34 | $3.71M | |
| 26.14 | $4.17M | |
| -1.10 | $5.42M | |
| -0.00 | $4.45M | |
| -6.83 | $544.75K | |
| -1.92 | $4.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pascal Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pascal Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pascal Biosciences Inc.'s PE Ratio?
How is the PE Ratio calculated for Pascal Biosciences Inc. (PSCBF)?
What is the highest PE Ratio for Pascal Biosciences Inc. (PSCBF)?
What is the 3-year average PE Ratio for Pascal Biosciences Inc. (PSCBF)?
What is the 5-year average PE Ratio for Pascal Biosciences Inc. (PSCBF)?
How does the current PE Ratio for Pascal Biosciences Inc. (PSCBF) compare to its historical average?